Related references
Note: Only part of the references are listed.Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolates
Huong Giang Le et al.
ACTA TROPICA (2019)
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates
Jung-Mi Kang et al.
MALARIA JOURNAL (2013)
Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent
Surendra K. Prajapati et al.
MALARIA JOURNAL (2011)
Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China
Hui Feng et al.
PARASITES & VECTORS (2011)
Sequence variation of ookinete surface proteins Pvs25 and Pvs28 of Plasmodium vivax isolates from Southern Mexico and their association to local anophelines infectivity
Lilia Gonzalez-Ceron et al.
INFECTION GENETICS AND EVOLUTION (2010)
Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran
Sedigheh Zakeri et al.
ACTA TROPICA (2009)
Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum
Alyssa E. Barry et al.
PLOS ONE (2009)
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
Yimin Wu et al.
PLOS ONE (2008)
Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720
A. Saul et al.
PARASITE IMMUNOLOGY (2007)
Malaria transmission-blocking vaccines: the bonus of effective malaria control
Robert W. Sauerwein
MICROBES AND INFECTION (2007)
The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms
AK Saxena et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Phase 1 vaccine trial of Pvs25H:: a transmission blocking vaccine for Plasmodium vivax malaria
EM Malkin et al.
VACCINE (2005)
A monkey's tale:: The origin of Plasmodium vivax as a human malaria parasite
AA Escalante et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28
T Tsuboi et al.
PARASITOLOGY INTERNATIONAL (2004)
DnaSP, DNA polymorphism analyses by the coalescent and other methods
J Rozas et al.
BIOINFORMATICS (2003)
Diversity and natural selection in Plasmodium vivax Duffy binding protein gene
J Cole-Tobian et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Transmission-blocking vaccine of vivax malaria
T Tsuboi et al.
PARASITOLOGY INTERNATIONAL (2003)
Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates
J Sattabongkot et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus
C Putaporntip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes
H Hisaeda et al.
INFECTION AND IMMUNITY (2000)
Share Paper
